101 related articles for article (PubMed ID: 16507412)
1. Gene targeting approach to selectively kill colon cancer cells, with hyperactive K-Ras pathway.
Dvory-Sobol H; Kazanov D; Arber N
Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S370-4. PubMed ID: 16507412
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy of pancreatic cancer targeting the K-Ras oncogene.
Lisiansky V; Naumov I; Shapira S; Kazanov D; Starr A; Arber N; Kraus S
Cancer Gene Ther; 2012 Dec; 19(12):862-9. PubMed ID: 23099885
[TBL] [Abstract][Full Text] [Related]
3. Selective suicide gene therapy of colon cancer exploiting the urokinase plasminogen activator receptor promoter.
Teimoori-Toolabi L; Azadmanesh K; Amanzadeh A; Zeinali S
BioDrugs; 2010 Apr; 24(2):131-46. PubMed ID: 20199127
[TBL] [Abstract][Full Text] [Related]
4. Novel approach to abuse the hyperactive K-Ras pathway for adenoviral gene therapy of colorectal cancer.
Naumov I; Kazanov D; Lisiansky V; Starr A; Aroch I; Shapira S; Kraus S; Arber N
Exp Cell Res; 2012 Jan; 318(2):160-8. PubMed ID: 22020090
[TBL] [Abstract][Full Text] [Related]
5. Selective suicide gene therapy of colon cancer cell lines exploiting fibroblast growth factor 18 promoter.
Teimoori-Toolabi L; Azadmanesh K; Zeinali S
Cancer Biother Radiopharm; 2010 Feb; 25(1):105-16. PubMed ID: 20187803
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic ras induces gastrin gene expression in colon cancer.
Nakata H; Wang SL; Chung DC; Westwick JK; Tillotson LG
Gastroenterology; 1998 Nov; 115(5):1144-53. PubMed ID: 9797369
[TBL] [Abstract][Full Text] [Related]
7. Selective expression of carcinoembryonic antigen promoter in cancer cell lines: targeting strategy for gene therapy in colorectal cancer.
Fichera A; Michelassi F; Arenas RB
Dis Colon Rectum; 1998 Jun; 41(6):747-54. PubMed ID: 9645743
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic Ras promotes butyrate-induced apoptosis through inhibition of gelsolin expression.
Klampfer L; Huang J; Sasazuki T; Shirasawa S; Augenlicht L
J Biol Chem; 2004 Aug; 279(35):36680-8. PubMed ID: 15213223
[TBL] [Abstract][Full Text] [Related]
9. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic activity of 5-fluorouracil in breast cancer cells transformed by low doses of ionizing α-particle radiation.
Ponce-Cusi R; Calaf GM
Int J Oncol; 2016 Feb; 48(2):774-82. PubMed ID: 26691280
[TBL] [Abstract][Full Text] [Related]
11. Transfected c-Ha-ras oncogene enhances karyotypic instability and integrates predominantly in aberrant chromosomes.
de Vries JE; Kornips FH; Marx P; Bosman FT; Geraedts JP; ten Kate J
Cancer Genet Cytogenet; 1993 May; 67(1):35-43. PubMed ID: 8504397
[TBL] [Abstract][Full Text] [Related]
12. Caspase-1 is a direct target gene of ETS1 and plays a role in ETS1-induced apoptosis.
Pei H; Li C; Adereth Y; Hsu T; Watson DK; Li R
Cancer Res; 2005 Aug; 65(16):7205-13. PubMed ID: 16103071
[TBL] [Abstract][Full Text] [Related]
13. [Effect of microRNA143 expression on cell proliferation in colonic carcinoma].
Liu H; Zhang SZ; Cai SR; Peng JP; Zheng S
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):498-501. PubMed ID: 19062714
[TBL] [Abstract][Full Text] [Related]
14. Constitutively active RAS signaling reduces 1,25 dihydroxyvitamin D-mediated gene transcription in intestinal epithelial cells by reducing vitamin D receptor expression.
DeSmet ML; Fleet JC
J Steroid Biochem Mol Biol; 2017 Oct; 173():194-201. PubMed ID: 28104492
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of apoptosis after thymineless stress is conferred by oncogenic K-Ras in colon carcinoma cells.
Houghton JA; Ebanks R; Harwood FG; Tillman DM
Clin Cancer Res; 1998 Nov; 4(11):2841-8. PubMed ID: 9829751
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells.
Konopka K; Spain C; Yen A; Overlid N; Gebremedhin S; Düzgüneş N
Cell Mol Biol Lett; 2009; 14(1):70-89. PubMed ID: 18839071
[TBL] [Abstract][Full Text] [Related]
17. [Transformation of NIH/3T3 cells and SW 480 cells displaying K-ras mutation].
Anker P; Lyautey J; Lefort F; Lederrey C; Stroun M
C R Acad Sci III; 1994 Oct; 317(10):869-74. PubMed ID: 7882132
[TBL] [Abstract][Full Text] [Related]
18. Transfection of K-rasAsp12 cDNA markedly elevates IL-1beta- and lipopolysaccharide-mediated inducible nitric oxide synthase expression in rat intestinal epithelial cells.
Takahashi M; Mutoh M; Shoji Y; Kamanaka Y; Naka M; Maruyama T; Sugimura T; Wakabayashi K
Oncogene; 2003 Oct; 22(48):7667-76. PubMed ID: 14576830
[TBL] [Abstract][Full Text] [Related]
19. CArG binding factor A (CBF-A) is involved in transcriptional regulation of the rat Ha-ras promoter.
Mikheev AM; Mikheev SA; Zhang Y; Aebersold R; Zarbl H
Nucleic Acids Res; 2000 Oct; 28(19):3762-70. PubMed ID: 11000268
[TBL] [Abstract][Full Text] [Related]
20. [miR-143 inhibits cell proliferation through targeted regulating the expression of K-ras gene in HeLa cells].
Qin HX; Cui HK; Pan Y; Hu RL; Zhu LH; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):893-897. PubMed ID: 27998464
[No Abstract] [Full Text] [Related]
[Next] [New Search]
